Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

NCT02216214 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

888

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder (OAB)

Interventions

DRUG: Mirabegron
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.